Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Paroxetine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1119012A details a safer diborane reduction for paroxetine intermediates. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical ingredients.
Patent CN105418502B details a novel rare earth catalyzed route for high-purity Paroxetine intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Discover a highly stereospecific process for paroxetine intermediates using chiral Ru-BINAP catalysts. Achieve superior purity and cost efficiency in API manufacturing.
Patent CN102285973B details a novel purification method for Paroxetine Hydrochloride achieving over 99.5% purity via silica gel chromatography and gradient recrystallization for reliable supply.
Novel patent CN120157611A details efficient paroxetine intermediate synthesis. Offers high purity, reduced waste, and scalable manufacturing for global supply chains.
Patent CN114605492A reveals a high-yield route for Paroved intermediates, offering cost-effective and scalable solutions for global API manufacturers.
Advanced catalytic method for paroxetine intermediate synthesis. Enhances optical purity and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN101974604B details a novel ionic liquid biocatalysis route for paroxetine intermediates, offering high optical purity and reduced environmental impact for reliable supply chains.
Patent CN101974604A reveals a green enzymatic route for paroxetine intermediates using ionic liquids, offering high purity and reduced environmental impact for API manufacturing.
Patent CN109020872B details a novel method converting unwanted paroxetine isomers into valuable racemic intermediates, offering significant cost reduction and supply chain efficiency for pharmaceutical manufacturers.